To ensure that the elevated levels of iRhom2 in OSCC were not due to persistent proinflammatory conditions or the presence of tumour microenvironment-associated immune cells, we examined proinflammatory markers and immune cell markers. The gene discussed is RHBDF2; the disease is neoplasm.